Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
PEN's Cash to Debt is ranked higher than
73% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. PEN: No Debt )
Ranked among companies with meaningful Cash to Debt only.
PEN' s Cash to Debt Range Over the Past 10 Years
Min: 2.28  Med: 5001.14 Max: No Debt
Current: No Debt
Equity to Asset -0.10
PEN's Equity to Asset is ranked lower than
95% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. PEN: -0.10 )
Ranked among companies with meaningful Equity to Asset only.
PEN' s Equity to Asset Range Over the Past 10 Years
Min: -0.11  Med: -0.11 Max: -0.1
Current: -0.1
-0.11
-0.1
Interest Coverage No Debt
PEN's Interest Coverage is ranked higher than
55% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. PEN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
PEN' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 2.40
PEN's Operating margin (%) is ranked higher than
51% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. PEN: 2.40 )
Ranked among companies with meaningful Operating margin (%) only.
PEN' s Operating margin (%) Range Over the Past 10 Years
Min: -1.27  Med: 0.57 Max: 2.4
Current: 2.4
-1.27
2.4
Net-margin (%) 1.79
PEN's Net-margin (%) is ranked higher than
52% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. PEN: 1.79 )
Ranked among companies with meaningful Net-margin (%) only.
PEN' s Net-margin (%) Range Over the Past 10 Years
Min: 1.79  Med: 3.20 Max: 4.61
Current: 1.79
1.79
4.61
ROA (%) 2.33
PEN's ROA (%) is ranked higher than
58% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. PEN: 2.33 )
Ranked among companies with meaningful ROA (%) only.
PEN' s ROA (%) Range Over the Past 10 Years
Min: 2.33  Med: 2.33 Max: 2.33
Current: 2.33
ROC (Joel Greenblatt) (%) 12.51
PEN's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. PEN: 12.51 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PEN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 12.51  Med: 12.51 Max: 12.51
Current: 12.51
» PEN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

PEN Guru Trades in

PEN Guru Trades in

Q3 2015

PEN Guru Trades in Q3 2015

RS Investment Management 115,701 sh (New)
Chuck Royce 1,000 sh (New)
PRIMECAP Management 100,000 sh (New)
Paul Tudor Jones 6,700 sh (New)
» More
Q4 2015

PEN Guru Trades in Q4 2015

Chuck Royce 1,000 sh (unchged)
RS Investment Management Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with PEN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 6.36
PEN's P/S is ranked lower than
93% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 2.22 vs. PEN: 6.36 )
Ranked among companies with meaningful P/S only.
PEN' s P/S Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 8.35
Current: 6.36
0
8.35
Current Ratio 5.54
PEN's Current Ratio is ranked higher than
80% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. PEN: 5.54 )
Ranked among companies with meaningful Current Ratio only.
PEN' s Current Ratio Range Over the Past 10 Years
Min: 3.93  Med: 4.74 Max: 5.54
Current: 5.54
3.93
5.54
Quick Ratio 3.93
PEN's Quick Ratio is ranked higher than
74% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. PEN: 3.93 )
Ranked among companies with meaningful Quick Ratio only.
PEN' s Quick Ratio Range Over the Past 10 Years
Min: 2.22  Med: 3.08 Max: 3.93
Current: 3.93
2.22
3.93
Days Inventory 258.85
PEN's Days Inventory is ranked lower than
78% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. PEN: 258.85 )
Ranked among companies with meaningful Days Inventory only.
PEN' s Days Inventory Range Over the Past 10 Years
Min: 258.85  Med: 258.85 Max: 258.85
Current: 258.85
Days Sales Outstanding 55.00
PEN's Days Sales Outstanding is ranked higher than
70% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. PEN: 55.00 )
Ranked among companies with meaningful Days Sales Outstanding only.
PEN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.71  Med: 54.36 Max: 55
Current: 55
53.71
55
Days Payable 20.09
PEN's Days Payable is ranked lower than
90% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. PEN: 20.09 )
Ranked among companies with meaningful Days Payable only.
PEN' s Days Payable Range Over the Past 10 Years
Min: 15.46  Med: 17.78 Max: 20.09
Current: 20.09
15.46
20.09

Valuation & Return

vs
industry
vs
history
Price/Graham Number 64.27
PEN's Price/Graham Number is ranked lower than
100% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 2.68 vs. PEN: 64.27 )
Ranked among companies with meaningful Price/Graham Number only.
PEN' s Price/Graham Number Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 64.27

More Statistics

Revenue(Mil) $126
EPS $ 0.09
Short Percentage of Float3.26%
52-Week Range $35.32 - 59.36
Shares Outstanding(Mil)29.89

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 179 219 262 311
EPS($) -0.10 -0.47 -0.39 0.02
EPS without NRI($) -0.10 -0.47 -0.39 0.02

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:0P8.Germany,
Penumbra Inc was incorporated in 2004 as a Delaware corporation under the name Penumbra. It is an interventional therapies company that designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. The Company sells its products to hospitals through its salesforce, as well as through distributors. It sells its products through direct sales organization in the United States, most of Europe, Canada and Australia. Its products include Penumbra System, ACE, Penumbra Coil 400, Penumbra SMART COIL, LIBERTY Stent, Apollo System, Ruby Coil and Indigo System. The Company competes with manufacturers and distributors of neurovascular and peripheral vascular medical devices. Its competitors are Boston Scientific, Johnson & Johnson, Medtronic, Stryker and Terumo. Its products are medical devices subject to extensive and ongoing regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (FD&C Act), and its implementing regulations, as well as other federal and state regulatory bodies in the United States and comparable authorities in other countries under other statutes and regulations.
» More Articles for PEN

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
The 5 Best IPOs of 2015 (ACRS,PEN) Jan 27 2016
Penumbra, Inc. – Value Analysis (NYSE:PEN) : January 19, 2016 Jan 19 2016
Penumbra, Inc. breached its 50 day moving average in a Bearish Manner : January 18, 2016 Jan 18 2016
Penumbra Introduces POD® Packing Coil for the Embolization of Peripheral Vessels and Aneurysms Jan 06 2016
Penumbra Introduces POD® Packing Coil for the Embolization of Peripheral Vessels and Aneurysms Jan 06 2016
Penumbra, Inc. to Present at the 34th Annual J.P. Morgan 2016 Healthcare Conference Dec 28 2015
Penumbra, Inc. to Present at the 34th Annual J.P. Morgan 2016 Healthcare Conference Dec 28 2015
PENUMBRA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Dec 23 2015
Penumbra (PEN) Shares March Higher, Can It Continue? Dec 18 2015
Hedge Funds Are Buying Tumi Holdings Inc (TUMI) Dec 05 2015
What Do Hedge Funds Think of MedAssets, Inc. (MDAS)? Nov 30 2015
Does Penumbra Inc (PEN) Represent a Stock Worth Your Portfolio? Nov 23 2015
Edited Transcript of PEN earnings conference call or presentation 12-Nov-15 9:30pm GMT Nov 12 2015
Penumbra posts 3Q profit Nov 12 2015
Penumbra posts 3Q profit Nov 12 2015
Penumbra, Inc. Reports Third Quarter 2015 Financial Results Nov 12 2015
PENUMBRA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 12 2015
Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Nov 05 2015
Penumbra, Inc. Schedules Third Quarter 2015 Earnings Release and Conference Call for November 12,... Oct 30 2015
Penumbra, Inc. Schedules Third Quarter 2015 Earnings Release and Conference Call for November 12,... Oct 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK